Concepedia

A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03

Takeshi Naruse, Tadashi Fukuda, Tetsuro Tanabe, Munetaka Ichikawa, Yoshiaki Oda, Shinji Tochihara, Kazuhiko Kimachi, Yoichiro Kino, Kohji Ueda

Vaccine · 2015 · 12 citations · 13 references

DOI

Concepts

References

13

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 503 citations

, , +14

AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland

Hanna Nohynek, Jukka Jokinen, Markku Partinen et al. · PLoS ONE · 2012 · 497 citations · Full text

, , +17

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

Emma R. Miller, Nick Andrews, L Stellitano et al. · BMJ · 2013 · 283 citations · Full text

, , +17

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture

Hartmut J. Ehrlich, Markus Müller, Helen May‐Lin Oh et al. · New England Journal of Medicine · 2008 · 275 citations · Full text

, , +16

H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

Philippe Moris, Robbert van der Most, Isabel Leroux‐Roels et al. · Journal of Clinical Immunology · 2010 · 163 citations · Full text

, , +17